Similar Items: Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma
- Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
- A pharmacokinetic and antimalarial efficacy evaluation of pyridodibemequines and their metabolites
- The determination of β-endosulfan and endosulfan sulfate in human serum with dialkylphosphate metabolites as urinary markers using LC-MS/MS electrospray ionization
- Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated Falciparum malaria
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
Author: Wiesner, Lubbe
- Development and validation of selective and sensitive LC-MS/MS Methods for determination of para-aminosalicyclic acid and cycloserine/terizidone applicable to clinical studies for the treatment of tuberculosis
- Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
- Screening rare filamentous actinobacteria for novel antimycobacterial compounds
- Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma
- A pharmacokinetic and antimalarial efficacy evaluation of pyridodibemequines and their metabolites
- Isolation and characterisation of antiplasmodial compounds from Xerophyta species and the bioavailability, metabolic and efficacy evaluation of 9-0-acetylhydnocarpin in a mouse model